Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

A new combination of tadalafil and finasteride improves drug performance and stability.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib was more effective than methotrexate for treating alopecia areata.